Novo Nordisk builds new plant for hemophilia treatments
Novo Nordisk is expanding its production of hemophilia products with a new 7,500 square meter facility in Kalundborg, Denmark.
Novo Nordisk is expanding its production of hemophilia products with a new 7,500 square meter facility in Kalundborg, Denmark.
Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Following the approval of 39 new drugs in 2012, and with a number of new pharmaceutical products already in their final stages of development, global pharma companies are optimistic about the next 12 months.